4128 Stock Overview
Researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Microbio Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$34.40 |
52 Week High | NT$49.33 |
52 Week Low | NT$31.38 |
Beta | 1.45 |
1 Month Change | -0.58% |
3 Month Change | -15.48% |
1 Year Change | -27.18% |
3 Year Change | -36.19% |
5 Year Change | 226.36% |
Change since IPO | 259.71% |
Recent News & Updates
Shareholder Returns
4128 | TW Personal Products | TW Market | |
---|---|---|---|
7D | -7.3% | -3.3% | -0.6% |
1Y | -27.2% | -19.5% | 28.5% |
Return vs Industry: 4128 underperformed the TW Personal Products industry which returned -19.5% over the past year.
Return vs Market: 4128 underperformed the TW Market which returned 28.5% over the past year.
Price Volatility
4128 volatility | |
---|---|
4128 Average Weekly Movement | 4.2% |
Personal Products Industry Average Movement | 3.9% |
Market Average Movement | 4.5% |
10% most volatile stocks in TW Market | 7.9% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4128 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4128's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | Tzen-Wen Chen | www.twmicrobio.com |
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services.
Microbio Co., Ltd. Fundamentals Summary
4128 fundamental statistics | |
---|---|
Market cap | NT$20.23b |
Earnings (TTM) | -NT$873.89m |
Revenue (TTM) | NT$1.68b |
12.0x
P/S Ratio-23.2x
P/E RatioIs 4128 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4128 income statement (TTM) | |
---|---|
Revenue | NT$1.68b |
Cost of Revenue | NT$1.03b |
Gross Profit | NT$648.19m |
Other Expenses | NT$1.52b |
Earnings | -NT$873.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.49 |
Gross Margin | 38.54% |
Net Profit Margin | -51.96% |
Debt/Equity Ratio | 0% |
How did 4128 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 01:58 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Microbio Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Evana Chen | Masterlink Securities Corp. |